CYRENAIC PHARMACEUTICALS INC has a total of 14 patent applications. Its first patent ever was published in 2011. It filed its patents most often in China, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are NOVARTIS INT PHARMACEUTICAL LTD, REACTION BIOLOGY CORP and MAMMEN MATHAI.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | Republic of Korea | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Russian Federation | 1 | |
#8 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Basic materials chemistry | |
#4 | Telecommunications | |
#5 | Digital networks |
# | Name | Total Patents |
---|---|---|
#1 | Karabelas Argeris N | 13 |
#2 | Pellegrini Lorenzo | 13 |
#3 | Luthringer Remy Henri | 12 |
#4 | Argeris N Karabelas | 1 |
#5 | Luthringer Remy H | 1 |
#6 | Lorenzo Pellegrini | 1 |
#7 | Remy Henri Luthringer | 1 |
Publication | Filing date | Title |
---|---|---|
CA2806017A1 | Methods of use of cyclic amide derivatives to treat schizophrenia | |
EP2595485A1 | Methods of use cyclic amide derivatives to treat sigma receptor-mediated disorders |